Sustaining benefits of nutritional therapy in young adults with phenylketonuria - A 2 year prospective study
Introduction: Phenylketonuria (PKU) is an inborn error of metabolism, which is caused by a deficiency in the enzyme phenylalanine hydroxylase (PAH). Life-long Phe-free diet impairs quality of life, especially in adolescents and young adults which take responsibility over their diet and therapy from...
Main Author: | Johannes Krämer |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-03-01
|
Series: | Molecular Genetics and Metabolism Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214426920300197 |
Similar Items
-
Retraction notice to “Sustaining benefits of nutritional therapy in young adults with phenylketonuria - A 2year prospective study” [Molecular Genetics and Metabolism Reports 22 (2020) 100573].
by: Johannes Krämer
Published: (2021-06-01) -
Diet Therapy and Nutritional Management of Phenylketonuria
Published: (2022) -
Case-control study about the acceptance of Pegvaliase in Phenylketonuria
by: Johannes Krämer
Published: (2020-03-01) -
Ten years of specialized adult care for phenylketonuria
by: Mütze, Ulrike, et al.
Published: (2016) -
Prospects for Cell-Directed Curative Therapy of Phenylketonuria (PKU)
by: Cary O. Harding
Published: (2019-12-01)